rheumatoid arthritis, scleroderma, polymyositis-dermatomyositis, systemic lupus erythematosus, mixed connective tissue disease, Sjogren syndrome, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, microscopic polyangiitis, IgG4-related disease.
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who meet the following of one of the diagnostic criteria. 1) 2010 ACR/EULAR classification criteria for rheumatoid arthritis. 2) 2013 classification criteria for systemic sclerosis 3) Bohan and Peter criteria for polymyositis and dermatomyositis 4) 2012 SLICC classification criteria for systemic lupus erythematosus 5) 2004 Preliminary diagnostic criteria for mixed connective tissue disease proposed by Ministry of Health, Labour and Welfare in Japan. 6) 2012 ACR classification criteria for Sjogren's syndrome 7) 1990 ACR classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis) 8) 1990 ACR classification of Wegener's granulomatosis (granulomatosis and angiitis) 9) 1999 diagnostic criteria for microscopic polyangiitis by Ministry of Health and Welfare in Japan. 10) 2011 Comprehensive diagnostic criteria for IgG4-related disease by Ministry of Health, Labour and Welfare in Japan.
Exclusion criteria
Exclusion criteria: 1) Patients who are judged to be inappropriate as a research subject by the principal investigator or research team members. 2) Patients who are considered to be difficult to obtain a valid consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| progression-free survival complications | — |
Countries
Japan
Contacts
Yamaguchi University Hospital Internal Medicine 2